UNSPSC 51471805: Proflavine

This classification denotes an anti-infective agent with the molecular formula C13H11N3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier CY3RNB3K4T, chemically known as 3,7-diamino-5-azaanthracene but generally known as proflavine, which bears US NIH Compound Identifier 7099. European Medicines Agency schedules Proflavine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10073MIG. The term PROFLAVINE is an International Non-Proprietary Name.

UNSPSC 51471805 Proflavine is a Commodity code. State and local governments buy proflavine as part of broader consumable supply procurements for public health and safety operations, though the recent opportunities block shows minimal direct sourcing of proflavine itself. Instead, proflavine appears tagged within larger janitorial, operational, and pharmaceutical supply contracts where it may serve as a minor line item among hundreds of other products. Hillsborough County Board of County Commissioners solicited consumable janitorial and operational supplies (ITB-26-00319) for the Fire Rescue Department across 47 stations, and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) issued an RFP for generic multi-source pharmaceuticals and OTC products serving state and local health facilities across multiple states including Oregon. The issuing bodies in recent activity span county government and regional cooperative purchasing consortia; no school districts, transit authorities, or other specialized public entities appear in the recent block.

Geographic spread is limited in the recent opportunities block to Florida (Hillsborough County) and Minnesota with multistate reach through MMCAP. Hillsborough County's ITB-26-00319, due July 24, 2026, targets janitorial and operational supplies with an estimated contract value of $765,679.84 for one year, with standard delivery within 10 days and emergency delivery within five business days to the Public Safety Operations Complex in Tampa. MMCAP's RFP (S1070000015802), due March 26, 2026, establishes multi-award contracts for generic pharmaceuticals and OTC products distributed through AmerisourceBergen (Cencora), Cardinal Health, and Morris & Dickson, with awards effective July 1, 2026, requiring vendors to certify compliance with current Good Manufacturing Practices and the Drug Supply Chain Security Act. The recent opportunities block contains no dedicated proflavine-specific solicitations, suggesting the code sees limited direct procurement activity at the state and local level.